Form 4: Onconova Therapeutics CEO Steven Fruchtman Reports Stock Transactions
SEC Form 4 Filing
CEO Steven Fruchtman reports the vesting and disposal of Onconova Therapeutics (ONTX) restricted stock units and common stock.
Summary
- On March 13, 2024, Steven M Fruchtman, the President and CEO of Onconova Therapeutics, Inc. (ONTX), reported transactions involving the company's stock.
- Fruchtman disposed of 23,111 shares of common stock upon the vesting of restricted stock units (RSUs).
- He also disposed of 8,727 shares of common stock on March 14, 2024, at a price of $0.9.
- Following these transactions, Fruchtman directly owns 74,792 shares of Onconova Therapeutics common stock and 46,222 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities. This filing indicates the CEO's transactions in Onconova Therapeutics stock.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/13/2023 | Date the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. |
| 03/13/2024 | Vesting of 23,111 restricted stock units and disposal of corresponding common stock. |
| 03/14/2024 | Disposal of 8,727 shares of common stock at $0.9 per share. |
| 03/15/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.